Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -209.09% and 63.06%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...
Idexx (IDXX) delivered earnings and revenue surprises of 7.14% and 1.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Integer (ITGR) delivered earnings and revenue surprises of 6.10% and 7.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Investors need to pay close attention to Sensus Healthcare (SRTS) stock based on the movements in the options market lately.
Sensus Healthcare, Inc. (SRTS) delivered earnings and revenue surprises of -34.62% and 1.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...
Idexx (IDXX) delivered earnings and revenue surprises of 6.77% and 1.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
The mean of analysts' price targets for Sensus Healthcare, Inc. (SRTS) points to an 81.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...
Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The consensus price target hints at a 72.6% upside potential for Sensus Healthcare, Inc. (SRTS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...
Health care stocks were hit hard early in the pandemic but these three have made quite a comeback. This article examines where they could go in 2023